z-logo
open-access-imgOpen Access
THE MOLECULAR TRIAD SYSTEM INVOLVING RANK/RANKL/OPG AS THERAPEUTIC TARGETS FOR METABOLIC BONE DISEASES
Author(s) -
Mekonnen Sisay,
Jemal Abdela,
Yallew Molla
Publication year - 2016
Publication title -
journal of drug delivery and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v6i6.1341
Subject(s) - rankl , osteoclast , bone resorption , bone remodeling , osteoporosis , osteoblast , metabolic bone disease , medicine , denosumab , osteoprotegerin , osteolysis , bone disease , endocrinology , cancer research , bioinformatics , chemistry , biology , receptor , dentistry , biochemistry , activator (genetics) , in vitro

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom